Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes

Jeesun Kim1, Paul K Y Wong

  • 1Department of Carcinogenesis, University of Texas M. D. Anderson Cancer Center, Smithville, TX 78957, USA.

Insights

Ataxia-telangiectasia (A-T) astrocytes exhibit impaired growth due to elevated reactive oxygen species (ROS). ATM protein kinase is crucial for stabilizing cellular redox status, preventing senescence-like defects in astrocytes.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Ataxia-telangiectasia (A-T) is characterized by progressive neurodegeneration.
  • Primary astrocytes from Atm(-/-) mice show reduced growth and survival in culture.
  • The underlying mechanisms for A-T astrocyte dysfunction are not fully understood.

Purpose of the Study:

  • To elucidate the mechanisms behind the impaired growth of Atm(-/-) astrocytes.
  • To investigate the role of reactive oxygen species (ROS) in A-T astrocyte senescence.
  • To identify potential therapeutic targets for A-T neurodegeneration.

Main Methods:

  • Primary astrocyte cultures from Atm(-/-) and control mice.
  • Measurement of intracellular ROS levels.
  • Analysis of ERK1/2 phosphorylation, p16(Ink4a), and Bmi-1 expression.
  • Treatment with MAPK/ERK inhibitor (PD98059) and antioxidant (N-acetyl-l-cysteine).

Main Results:

  • Atm(-/-) astrocytes display elevated intracellular ROS and a senescence-like growth defect.
  • Increased ERK1/2 phosphorylation and p16(Ink4a) levels were observed in Atm(-/-) astrocytes.
  • ROS-induced p16(Ink4a) up-regulation correlated with ERK1/2-dependent Bmi-1 downregulation.
  • PD98059 and N-acetyl-l-cysteine treatment rescued the proliferation defect in Atm(-/-) astrocytes.

Conclusions:

  • ATM is essential for maintaining normal astrocyte growth by stabilizing intracellular redox status.
  • Impaired ROS control is the molecular basis for limited Atm(-/-) astrocyte growth.
  • A mechanism involving ERK1/2 activation and Bmi-1 regulation of p16(Ink4a) may mediate the defect.
  • These findings suggest potential therapeutic targets for A-T neurodegeneration.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...